CD19 and B-cell chronic lymphocytic leukemia: To identify potential prognostic markers or therapeutic targets by pinpointing metabolic vulnerabilities in CLL, differential expression analysis identified 34 DEGs associated to fatty acid metabolism in expression arrays of 180 CLL blood samples and 32 sorted CD19+ B cell samples from healthy donors in GSE50006 (Figure S1A).